Related Experiment Video

Updated: Apr 2, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.6K

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Franck Toledo1, Geoffrey M Wahl

  • 1Institut Curie, Centre de Recherche, UMR CNRS 7147, 26 rue d'Ulm, 75248 Paris Cedex 05, France. franck.toledo@curie.fr

Nature Reviews. Cancer
|November 28, 2006
PubMed

Insights

Understanding the tumor suppressor p53 pathway is key for cancer treatment. This review highlights that while p53 modifications matter, MDM2 and MDM4 proteins are crucial regulators, with MDM4 being a promising drug target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Mutations in the TP53 gene, encoding the tumor suppressor p53, occur in 50% of human cancers.
  • Elevated levels of negative regulators MDM2 and MDM4 (MDMX) suppress p53 function in the remaining cancers.
  • Elucidating p53 regulation is critical for developing broad-spectrum anticancer therapies targeting this pathway.

Purpose of the Study:

  • To review the regulatory roles of p53 post-translational modifications, MDM2, and MDM4 in cancer.
  • To identify key targets for novel anticancer drug development based on p53 pathway modulation.

Main Methods:

  • Comprehensive review of in vitro studies.
  • Analysis of human tumor data.
  • Examination of recent mouse models.

Main Results:

  • p53 post-translational modifications play a modulatory role in p53 function.
  • MDM2 and MDM4 exhibit profound regulatory roles in controlling p53 activity.
  • MDM4 inactivation is essential for complete p53 activation, positioning it as a viable drug target.

Conclusions:

  • MDM4 is a critical and independent target for anticancer drug development.
  • Targeting MDM4 offers a promising strategy for reactivating p53 and treating a wide range of cancers.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K
Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.9K

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K